Judith Aberg
Infectious Disease · New York, NYNPI 1902969645
Payments from drug & device makers
Across 540 payments — averaging $27,448 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$4.7M
- Gilead$3.4M
- Regeneron$2.1M
- Janssen Research & Development, LLC$1.8M
- Emergent Biosolutions Inc.$1.3M
- Viiv Healthcare Company$1.1M
- plus $413K from 8 others
Across 4 payments — averaging $1569.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$5K
- Regeneron$2K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 110 | $4,734,990 |
| Gilead | 19 | $3,352,036 |
| Regeneron | 76 | $2,101,181 |
| Janssen Research & Development, LLC | 57 | $1,802,510 |
| Emergent Biosolutions Inc. | 10 | $1,280,419 |
| Viiv Healthcare Company | 153 | $1,137,882 |
| Macrogenics, Inc. | 24 | $295,232 |
| GSK | 22 | $61,174 |
| Merck | 48 | $45,596 |
| Janssen Scientific Affairs, LLC | 9 | $4,318 |
| Theratechnologies Inc. | 9 | $4,276 |
| Invivyd Inc | 1 | $1,750 |
| Medicure Pharma Inc. | 1 | $500 |
| Johnson & Johnson | 1 | $25 |
How this compares
$14,821,888 in reported general payments places this provider in the 95th percentile of 799 infectious disease providers in New York.
Other infectious disease in New York
- Wafaa El SadrNew York$119.1M
- Magdalena SobieszczykNew York$2.9M
- Kristen MarksNew York$2.8M
- Genovefa PapanicolaouNew York$2.7M
- Thomas WalshNew York$1.4M
- Sean LiuNew York$1.4M
- Martin MarkowitzNew York$1.4M
- Angelica KottkampNew York$1.2M
- Michelle CespedesNew York$819K
- Vanessa RaabeNew York$728K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.